7.09 USD
+0.02 (+0.28%)
KMDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 530 industry peers in the Biotechnology industry. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. KMDA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, KMDA could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
KMDA had positive earnings in the past year.
KMDA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
KMDA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of KMDA (5.42%) is better than 91.70% of its industry peers.
KMDA has a Return On Equity of 7.71%. This is amongst the best in the industry. KMDA outperforms 91.51% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.66%, KMDA belongs to the top of the industry, outperforming 92.64% of the companies in the same industry.
KMDA had an Average Return On Invested Capital over the past 3 years of 2.98%. This is significantly below the industry average of 18.22%.
The last Return On Invested Capital (6.66%) for KMDA is above the 3 year average (2.98%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.71% | ||
| ROIC | 6.66% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 11.70%, KMDA belongs to the best of the industry, outperforming 91.70% of the companies in the same industry.
In the last couple of years the Profit Margin of KMDA has declined.
Looking at the Operating Margin, with a value of 15.88%, KMDA belongs to the top of the industry, outperforming 93.58% of the companies in the same industry.
KMDA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 43.75%, KMDA is in the better half of the industry, outperforming 74.53% of the companies in the same industry.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.88% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% |
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so KMDA is destroying value.
KMDA has about the same amout of shares outstanding than it did 1 year ago.
KMDA has more shares outstanding than it did 5 years ago.
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
KMDA has an Altman-Z score of 3.30. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of KMDA (3.30) is better than 68.68% of its industry peers.
The Debt to FCF ratio of KMDA is 0.63, which is an excellent value as it means it would take KMDA, only 0.63 years of fcf income to pay off all of its debts.
KMDA has a better Debt to FCF ratio (0.63) than 94.72% of its industry peers.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.04, KMDA is in line with its industry, outperforming 40.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 3.3 |
ROIC/WACC0.78
WACC8.51%
2.3 Liquidity
KMDA has a Current Ratio of 4.03. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
KMDA has a Current ratio (4.03) which is comparable to the rest of the industry.
A Quick Ratio of 2.24 indicates that KMDA has no problem at all paying its short term obligations.
KMDA has a worse Quick ratio (2.24) than 72.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.03 | ||
| Quick Ratio | 2.24 |
3. Growth
3.1 Past
KMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.57%, which is quite impressive.
Measured over the past years, KMDA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.60% on average per year.
Looking at the last year, KMDA shows a quite strong growth in Revenue. The Revenue has grown by 10.36% in the last year.
KMDA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.82% yearly.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
KMDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.56% yearly.
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 9.40% on average per year.
EPS Next Y41.23%
EPS Next 2Y28.87%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue Next Year12.48%
Revenue Next 2Y11.19%
Revenue Next 3Y9.4%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.69, the valuation of KMDA can be described as rather expensive.
KMDA's Price/Earnings ratio is rather cheap when compared to the industry. KMDA is cheaper than 94.34% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.59. KMDA is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 16.42, which indicates a correct valuation of KMDA.
Based on the Price/Forward Earnings ratio, KMDA is valued cheaply inside the industry as 95.85% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of KMDA to the average of the S&P500 Index (24.03), we can say KMDA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.69 | ||
| Fwd PE | 16.42 |
4.2 Price Multiples
KMDA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. KMDA is cheaper than 97.36% of the companies in the same industry.
KMDA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KMDA is cheaper than 94.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.31 | ||
| EV/EBITDA | 8.11 |
4.3 Compensation for Growth
KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
KMDA's earnings are expected to grow with 26.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y28.87%
EPS Next 3Y26.56%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.75%. Purely for dividend investing, there may be better candidates out there.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 1.02. KMDA pays more dividend than 98.68% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, KMDA pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.75% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y28.87%
EPS Next 3Y26.56%
NASDAQ:KMDA (12/24/2025, 7:42:47 PM)
7.09
+0.02 (+0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.39%
Inst Owner Change3.21%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap408.95M
Revenue(TTM)174.79M
Net Income(TTM)20.44M
Analysts84.44
Price Target15.05 (112.27%)
Short Float %0.14%
Short Ratio0.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.75% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)0%
PT rev (3m)-7.81%
EPS NQ rev (1m)-18.42%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)-5.88%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.69 | ||
| Fwd PE | 16.42 | ||
| P/S | 2.34 | ||
| P/FCF | 22.31 | ||
| P/OCF | 14.44 | ||
| P/B | 1.54 | ||
| P/tB | 1.74 | ||
| EV/EBITDA | 8.11 |
EPS(TTM)0.36
EY5.08%
EPS(NY)0.43
Fwd EY6.09%
FCF(TTM)0.32
FCFY4.48%
OCF(TTM)0.49
OCFY6.93%
SpS3.03
BVpS4.6
TBVpS4.07
PEG (NY)0.48
PEG (5Y)N/A
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.71% | ||
| ROCE | 8.43% | ||
| ROIC | 6.66% | ||
| ROICexc | 8.52% | ||
| ROICexgc | 9.66% | ||
| OM | 15.88% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% | ||
| FCFM | 10.49% |
ROA(3y)1.84%
ROA(5y)2.59%
ROE(3y)2.55%
ROE(5y)3.2%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.78%
ROICexc(5y)N/A
ROICexgc(3y)8.93%
ROICexgc(5y)N/A
ROCE(3y)3.78%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.12%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.72%
OM growth 3YN/A
OM growth 5Y-7.02%
PM growth 3YN/A
PM growth 5Y-12.51%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 65.68% | ||
| Cap/Sales | 5.72% | ||
| Interest Coverage | 35.82 | ||
| Cash Conversion | 65.9% | ||
| Profit Quality | 89.64% | ||
| Current Ratio | 4.03 | ||
| Quick Ratio | 2.24 | ||
| Altman-Z | 3.3 |
F-Score7
WACC8.51%
ROIC/WACC0.78
Cap/Depr(3y)51.63%
Cap/Depr(5y)66.68%
Cap/Sales(3y)4.57%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y41.23%
EPS Next 2Y28.87%
EPS Next 3Y26.56%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.48%
Revenue Next 2Y11.19%
Revenue Next 3Y9.4%
Revenue Next 5YN/A
EBIT growth 1Y56.4%
EBIT growth 3YN/A
EBIT growth 5Y-2.54%
EBIT Next Year134.37%
EBIT Next 3Y34.69%
EBIT Next 5YN/A
FCF growth 1Y918.17%
FCF growth 3YN/A
FCF growth 5Y7.84%
OCF growth 1Y325.9%
OCF growth 3YN/A
OCF growth 5Y11.54%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
Can you provide the valuation status for KAMADA LTD?
ChartMill assigns a valuation rating of 8 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
Can you provide the financial health for KMDA stock?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.
Can you provide the expected EPS growth for KMDA stock?
The Earnings per Share (EPS) of KAMADA LTD (KMDA) is expected to grow by 41.23% in the next year.